Serveur d'exploration Covid (26 mars) - Analysis (new)

Index « Auteurs » - entrée « David Cyranoski »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
David Chi Cheong Wan < David Cyranoski < David E. Ost  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000089 (2020) David CyranoskiThis scientist hopes to test coronavirus drugs on animals in locked-down Wuhan.
000281 (2020) David CyranoskiMystery deepens over animal source of coronavirus.
000537 (2020) Ewen Callaway ; David CyranoskiChina coronavirus: Six questions scientists are asking.

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Animals
3Coronavirus Infections (virology)
3Humans
3Pneumonia, Viral (virology)
2Antiviral Agents (pharmacology)
2Antiviral Agents (supply & distribution)
2Antiviral Agents (therapeutic use)
2China (epidemiology)
2Coronavirus (genetics)
2Coronavirus (isolation & purification)
2Coronavirus Infections (drug therapy)
2Coronavirus Infections (transmission)
2Pneumonia, Viral (drug therapy)
2Pneumonia, Viral (transmission)
2Severe Acute Respiratory Syndrome (drug therapy)
2Severe Acute Respiratory Syndrome (virology)
2Zoonoses (transmission)
2Zoonoses (virology)
1Anti-HIV Agents (pharmacology)
1Anti-HIV Agents (therapeutic use)
1Asymptomatic Infections (epidemiology)
1Basic Reproduction Number (statistics & numerical data)
1Chiroptera (virology)
1Clinical Trials as Topic
1Coronavirus (drug effects)
1Coronavirus (pathogenicity)
1Coronavirus Infections (epidemiology)
1Coronavirus Infections (mortality)
1Coronavirus Infections (veterinary)
1Disease Models, Animal
1Drug Evaluation, Preclinical
1Europe (epidemiology)
1Eutheria (virology)
1Mice
1Middle East Respiratory Syndrome Coronavirus (drug effects)
1Patient Selection
1Peptidyl-Dipeptidase A (genetics)
1Peptidyl-Dipeptidase A (metabolism)
1Pneumonia, Viral (epidemiology)
1Pneumonia, Viral (mortality)
1Pneumonia, Viral (veterinary)
1Quarantine (methods)
1Reproducibility of Results
1SARS Virus (drug effects)
1Time Factors
1Uncertainty
1United States (epidemiology)
1Viral Vaccines (supply & distribution)
1World Health Organization (organization & administration)
1Zoonoses (diagnosis)
1Zoonoses (epidemiology)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/new/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/Author.i -k "David Cyranoski" 
HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/Author.i  \
                -Sk "David Cyranoski" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/new/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    new
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    David Cyranoski
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021